REFERENCES

1. Horwitz MS, Corey SJ, Grimes HL, Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am 2013;27:19-41, vii.

2. Klein C. Congenital neutropenia. Hematology Am Soc Hematol Educ Program 2009:344-50.

3. Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers 2017;3:17032.

4. Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011;6:26.

5. Touw IP. Congenital neutropenia: disease models guiding new treatment strategies. Curr Opin Hematol 2022;29:27-33.

6. Papadaki HA, Mavroudi I, Almeida A, et al. Congenital and acquired chronic neutropenias: challenges, perspectives and implementation of the EuNet-INNOCHRON action. Hemasphere 2020;4:e406.

7. Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003;34:70-4.

8. Skokowa J. Circumventing mutation to nix neutropenia. N Engl J Med 2021;384:1956-8.

9. Vilboux T, Lev A, Malicdan MC, et al. A congenital neutrophil defect syndrome associated with mutations in VPS45. N Engl J Med 2013;369:54-65.

10. Mir P, Klimiankou M, Findik B, et al. New insights into the pathomechanism of cyclic neutropenia. Ann N Y Acad Sci 2020;1466:83-92.

11. Dale DC, Bolyard AA, Shannon JA, et al. Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor. Blood Adv 2022;6:3861-9.

12. Rosenberg PS, Zeidler C, Bolyard AA, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010;150:196-9.

13. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 2003;35:90-6.

14. Majewski P, Majchrzak-Gorecka M, Grygier B, Skrzeczynska-Moncznik J, Osiecka O, Cichy J. Inhibitors of serine proteases in regulating the production and function of neutrophil extracellular traps. Front Immunol 2016;7:261.

15. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010;191:677-91.

16. Skrzeczynska-Moncznik J, Zabieglo K, Osiecka O, et al. Differences in staining for neutrophil elastase and its controlling inhibitor SLPI reveal heterogeneity among neutrophils in psoriasis. J Invest Dermatol 2020;140:1371-1378.e3.

17. Zabieglo K, Majewski P, Majchrzak-Gorecka M, et al. The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps. J Leukoc Biol 2015;98:99-106.

18. Nasri M, Ritter M, Mir P, et al. CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica 2020;105:598-609.

19. Horwitz MS. Neutrophil elastase: nonsense lost in translation. Cell Stem Cell 2021;28:790-2.

20. Nanua S, Murakami M, Xia J, et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood 2011;117:3539-47.

21. Rao S, Yao Y, Soares de Brito J, et al. Dissecting ELANE neutropenia pathogenicity by human HSC gene editing. Cell Stem Cell 2021;28:833-845.e5.

22. Garg B, Mehta HM, Wang B, Kamel R, Horwitz MS, Corey SJ. Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response. J Biol Chem 2020;295:7492-500.

23. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem 2001;276:14230-41.

24. Grenda DS, Murakami M, Ghatak J, et al. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 2007;110:4179-87.

25. Nustede R, Klimiankou M, Klimenkova O, et al. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol 2016;172:219-27.

26. Olofsen PA, Bosch DA, Roovers O, et al. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations. Blood Adv 2021;5:775-86.

27. Tidwell T, Wechsler J, Nayak RC, et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood 2014;123:562-9.

28. Köllner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006;108:493-500.

29. Liu Q, Zhang L, Shu Z, Ding Y, Tang XM, Zhao XD. Two paternal mosaicism of mutation in ELANE causing severe congenital neutropenia exhibit normal neutrophil morphology and ROS production. Clin Immunol 2019;203:53-8.

30. Nayak RC, Trump LR, Aronow BJ, et al. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells. J Clin Invest 2015;125:3103-16.

31. Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 2005;105:3397-404.

32. Makaryan V, Kelley ML, Fletcher B, Bolyard AA, Aprikyan AA, Dale DC. Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol 2017;102:1143-51.

33. du Bois RM, Bernaudin JF, Paakko P, Hubbard R, Takahashi H, et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. Blood 1991;77:2724-30.

34. Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 1997;61:695-702.

35. Allaeys I, Ribeiro de Vargas F, Bourgoin SG, Poubelle PE. Human inflammatory neutrophils express genes encoding peptidase inhibitors: production of elafin mediated by NF-κB and CCAAT/enhancer-binding protein β. J Immunol 2021;206:1943-56.

36. Badola S, Spurling H, Robison K, et al. Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data. Genomics 2006;88:173-84.

37. Klimenkova O, Ellerbeck W, Klimiankou M, et al. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 2014;123:1239-49.

38. Dannenmann B, Zahabi A, Mir P, et al. Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34⁺ cells preceding leukemic transformation. Exp Hematol 2019;71:51-60.

39. Qiu Y, Zhang Y, Hu N, Dong F. A Truncated granulocyte colony-stimulating factor receptor (g-csfr) inhibits apoptosis induced by neutrophil elastase G185R mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA. J Biol Chem 2017;292:3496-505.